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Lipid bindingHuman ﬁbroblast growth factor (hFGF-1) is a ∼17 kDa heparin binding cytokine. It lacks the conventional
hydrophobic N-terminal signal sequence and is secreted through non-classical secretion routes. Under
stress, hFGF-1 is released as a multiprotein complex consisting of hFGF-1, S100A13 (a calcium binding
protein), and p40 synaptotagmin (Syt1). Copper (Cu2+) is shown to be required for the formation of the
multiprotein hFGF-1 release complex (Landriscina et al. ,2001; Di Serio et al., 2008). Syt1, containing the
lipid binding C2B domain, is believed to play an important role in the eventual export of the hFGF-1 across
the lipid bilayer. In this study, we characterize Cu2+ and lipid interactions of the C2B domain of Syt1 using
multidimensional NMR spectroscopy. The results highlight how Cu2+ appears to stabilize the protein bound
to pS vesicles. Cu2+ and lipid binding interface mapped using 2D 1H–15N heteronuclear single quantum
coherence experiments reveal that residues in β-strand I contributes to the unique Cu2+ binding site in the
C2B domain. In the absence of metal ions, residues located in Loop II and β-strand IV contribute to binding to
unilamelar pS vesicles. In the presence of Cu2+, additional residues located in Loops I and III appear to
stabilize the protein-lipid interactions. The results of this study provide valuable information towards
understanding the molecular mechanism of the Cu2+-induced non-classical secretion of hFGF-1.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The human acidic ﬁbroblast growth factor (hFGF-1) [1,2], a potent
mitogen, is a ubiquitously expressed member of the FGF family [3–7].
hFGF-1 is a ∼17-kDa all-β-sheet protein and is involved in the
regulation of a wide variety of important cellular processes such as
angiogenesis, morphogenesis, inﬂammation, tumor growth, and
wound healing [8]. Interestingly, unlike most secreted proteins,
hFGF-1 lacks the N-terminal signal sequence and therefore is secreted
through routes that are independent of the classical endoplasmic
reticulum (ER)–Golgi pathway [9].
The precise mechanism for the secretion of the signal peptide-less
proteins is not completely understood. Several studies show hFGF-1 is
released in response to stresses such as heat shock, hypoxia,
cultivation under low serum conditions, and cell treatment with
low-density lipoproteins (LDLs) [10–13]. Jackson et al. [11] demon-tor-1; Syt1, Synaptotagmin 1;
nuclear magnetic resonance
+1 479 575 4049.
ll rights reserved.strated that the formation of FGF-1 homodimer is a prerequisite for its
release in response to heat shock and hypoxia. Homodimer formation
is facilitated by copper (Cu2+)-induced oxidation of a speciﬁc cysteine
residue (Cys30) in hFGF-1. Cu2+ has been demonstrated to be
required for the assembly of multiprotein hFGF-1 release complex.
Prudovsky et al. [2,14], investigating the spatio-temporal character-
istics of the non-classical release of hFGF-1 using real-time confocal
Microscopy, showed the formation of a multiprotein hFGF-1 release
complex near the inner surface of the plasma membrane [14]. The
proteins assembled in the multiprotein hFGF-1 release complex
include the FGF-1 homodimer, S100A13 (a calcium binding protein),
and the p40 form of synaptotagmin, a protein involved in secretory
vesicle docking [15,16]. More recently, the non-classically secreted
enzyme sphingosine kinase 1 is also suggested to be a part of the
hFGF-1 release complex [10,17–20]. However, to date, details of the
molecular events leading to the formation of multiprotein FGF-1
release complex, as well as the mechanism underlying the export of
this growth factor to the extracellular compartment is still an enigma.
Synaptotagmin-1 (Syt-1) is a 65 kDa synaptic vesicle protein
containing a short intravesicular N-terminus, a single-pass trans-
membrane domain, and a C-terminal extravesicular cytosolic portion
including two calcium binding C2 (C2A and C2B) domains (Fig. 1)
Fig. 1. Three-dimensional structure of the C2A (orange) and C2B (blue) domains of
Syt1. The linker region connecting the C2 domains is shown in magenta. The structure
was generated using the pdb accession code 2R83.
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partially penetrate into the lipid bilayer, and the interactions between
C2A, C2B and Ca2+ are believed to be critical for the membrane fusion
activity of Syt-1. The 40-kDa form of synaptotagmin (p40 Syt1)
represents a product of the alternative in-frame initiation of
synaptotagmin mRNA translation [27–29]. It lacks the intravesicular
and transmembrane domains and corresponds to the extravesicular
domain of p65 Syt1. p40 Syt 1 is amember of the FGF1 export complex
which is critically important for stress-induced nonclassical FGF1
release [19,30]. Although, the exact role of the C2 domains of Syt-1 in
the non-classical secretion of FGF-1 is still unclear, it is believed that
these lipid-binding domains are important for anchoring the multi-
protein hFGF-1 release complex to the cell membrane. Indeed,
mutation of lysines 326, 327 and 331 in C2B domain drastically
reduced the membrane destabilizing activity of p40 Syt1 and
abolished its nonclassical export [31].
The C2B domain has a β-sandwich structure formed by two layers
of four antiparallel β-strands. Unlike the C2A domain, which lacks
helical segments, the C2B domain contains two α-helices (Fig. 1) [32].
The helical segment located at the C-terminal end of the molecule is
tightly packed against residues in β-strands III, VI, and VII [32,33]. A
stretch of negatively charged residues in the C-terminal helix is in close
proximity to a patch of positively charged residues that are implicated
in C2B domain's interaction with other proteins. The striking dipolar
distribution of charged residues on one side of the molecule is a
characteristic feature of the structure of the C2B domain. Two distinct
Ca2+ binding sites have been characterized in the C2B domain [32].
However, additional calciumbinding sites could not be ruled out in the
presence of interacting protein or lipid components [4,15,33–35].
Although the Ca2+-dependent lipid binding afﬁnity of the C2B domain
has been well characterized, very little is known about the structural
role of this domain in the Cu2+-mediated non-classical secretion of
hFGF-1. In this study,we investigated the inﬂuence ofmetal ions (Ca2+
and Cu2+) on the structural stability and lipid binding afﬁnity of the
C2B domain. In addition, the lipid-binding interface on the C2B
domain, in the absence and presence of the metal ions, has been
characterized using multidimensional NMR spectroscopy. The results
of this study clearly show that Cu2+ binds to distinct sites and
signiﬁcantly inﬂuences the lipid binding afﬁnity of the C2B domain.
2. Materials and methods
Ingredients for Luria Broth were obtained from EMD Bio-
sciences. Aprotinin, pepstatin, leupeptin, phenylmethylsulfonylﬂuoride, triton X-100, terbium chloride, and β-mercaptoethanol
were obtained from Sigma Co. (St. Louis). Heparin sepharose and
glutathione sepharose were obtained from GE Healthcare. Labeled
15NH4Cl and D2O were purchased from Cambridge Isotope
Laboratories. All other chemicals used were of high quality
analytical grade. All experiments were performed at 25 °C. Unless
speciﬁed, all solutions were made in 10 mM Tris buffer (pH 7.5)
containing 100 mM NaCl.
2.1. Expression and puriﬁcation of the C2B domain
cDNA encoding the C2B domain of synaptotagmin I (residues 270
to 421) and p40 Syt1 was kindly provided by Professor Thomas
Sudhof. Escherichia coli expressing GST-tagged C2B were induced
with isopropyl-β-D-thiogalactopyranoside (IPTG) when absorbance
(at 600 nm) reached 0.5–0.6, and the cells were harvested by
centrifugation at 6000 rpm after 4 h of induction. The harvested cells
were resuspended, and cell walls were ruptured by sonication. The
cell lysate was centrifuged at 16,000 rpm for 20 min. The supernatant
was then incubated with glutathione sepharose, and the resin was
then extensively washed with Tris buffer saline (TBS, 20 mM Tris
150 mM NaCl) and 20 mM Tris containing 1M NaCl to remove
impurities. The column was then equilibrated with cleavage buffer
(20 mM Tris, 0.2 M NaCl, 2.5 mM CaCl2, pH8.0), and an on-column
thrombin cleavage was carried out (2 NIH units/mL) at 25 °C for 3 h.
The cleaved protein (C2B) was eluted with TBS buffer as described by
Ubach et al. [33]. The homogeneity of the protein was then assessed
using SDS-PAGE, and the concentration of the protein was estimated
on the [33] basis of the extinction coefﬁcient (ɛ= 19940 M−1 cm−1)
value calculated from the amino acid sequence of the C2B domain.
Complete removal of nucleotide impurities was veriﬁed by recording
UV spectrum of the protein.
2.2. Preparation of isotope-enriched C2B domain
Uniform 15N labeling of C2B was achieved using M9 minimal
medium containing 15NH4Cl. To achieve maximal expression yields,
the composition of the M9 medium was modiﬁed by the addition of a
mixture of vitamins [36–37]. The expression host strain E. coli BL21
(DE3) is a vitamin B1-deﬁcient host, and hence, the medium was
supplemented with thiamine (vitamin B1) [36].
2.3. Preparation of the lipid vesicles
Small unilamellar vesicles (SUV) were prepared by dissolving
the solid phospholipids (phosphatidyl serine (pS)) purchased from
Avanti polar lipid, Inc.) in chloroform, followed by evaporation to
dryness under nitrogen. The lipid ﬁlm was suspended in 10 mM
Tris buffer (pH 7.5) containing 100 mM NaCl and sonicated in an
AQUASONIC-75D12 bath-type sonicator until optical clarity was
obtained. The solution was ﬁnally centrifuged for 5 min at
14000 rpm in an Eppendorf microfuge before use and stored for
a maximum of 6 h in ice.
2.4. NMR experiments
All NMR experiments were performed on a Bruker Avance-700
MHz NMR spectrometer equipped with a cryoprobe at 30 °C. 15N
decoupling during data acquisition was accomplished using the
globally optimized altering phase rectangular pulse sequence, and
2048 complex data points were collected in the 15N dimension. 1H–
15N HSQC spectra were recorded at 32 scans. The concentration of the
protein sample usedwas 0.1mM in 90% H2O and 10 % D2O prepared in
50 mM MES buffer containing 150 mM NaCl and 2 mM DTT (pH 6.3).
The spectra were processed on a Windows workstation using XWIN-
NMR and Sparky software [38].
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S100A13 and p40 Syt1 are both Ca2+ binding proteins that
chaperone the Cu2+-mediated non-classical secretion of hFGF-1 [11].
Recent evidence suggests that the C2 domains of p40 Syt1 bind to
Cu2+ and facilitate the anchoring of hFGF-1 to the membrane bilayer
[23,24]. In addition, C2B is known to preferentially bind to small
unilamelar phosphatidylserine vesicles [26,39]. In this context, it will
be interesting to map the pS binding sites on the C2B domain, in the
presence and absence of Cu2+, using multidimensional NMR
spectroscopy.
3.1. Conformational changes monitored by 2D NMR spectroscopy
NMR spectroscopy is a powerful tool to monitor protein-ligand or
protein-protein interactions [40]. Ligand binding sites on proteins are
routinely mapped using 2D 1H–15N heteronuclear single quantum
coherence (HSQC) spectroscopy [41]. A HSQC spectrum of a protein is
a ﬁngerprint of its backbone conformation [42]. Each 1H–15N cross-
peak in the spectrum is representative of the microenvironment of a
backbone amide proton in a given conformation of proteins.
Therefore, backbone conformational transitions induced by metal
(Cu2+)/pS vesicles can be readily monitored from the chemical shift
perturbation due to decrease in intensity of the crosspeaks in the 1H–
15N HSQC spectrum. The 1H–15N HSQC spectrum of the apoC2B
domain is well dispersed, suggesting that most of the backbone of the
protein is in an ordered conformation. Assignment of all the 1H–15N
crosspeaks in the HSQC spectrum of the C2B domain was previously
achieved by Fernandez et al. [32].
Copper (Cu2+) is a paramagnetic ion, and therefore, the 1H–15N
crosspeaks at the vicinity of the Cu2+-binding site are expected toFig. 2. 1H–15N HSQC spectra of the C2B domain in the absence (in red) (Panel A) and in the p
depicting crosspeaks of residues that show signiﬁcant loss in intensity in the presence of pS
cross-peak intensity observed in the presence of Cu2+ indicates that these residues are in tbroaden (and consequently disappear) with the reciprocal of the sixth
power of the Cu2+-nucleus distance [43]. Selected crosspeaks in the
1H–15N HSQC spectrum of the apoC2B domain, show progressively
decreased intensities with increased additions of Cu2+. However, we
did not observe any signiﬁcant perturbation of crosspeaks in the 1H–
15N HSQC spectrum when C2B domain was titrated with Cu2+. The
1H–15N crosspeaks that completely disappeared (at a 1: 4 ratio of the
C2B domain to Cu2+ concentration) are Cys277, Phe278, Leu280,
Gly306, Lys324, Thr 328, Thr329, Ile330, Asn333, Val357, Val358,
Ile367, Gly368, and Lys375 (Figs. 2A and 3A). Most of these residues
are present in β-strand I, Loop1, β-strand IV, LoopII, β-strand V1, and
LoopIII of the structure of the C2B domain. Interestingly, some of the
residues in Loops I, II and III (Gly306, Ile367, and Lys375) are part of
the Ca2+-binding site in the C2B domain [32]. These observations
suggest that Cu2+ shares common binding sites with Ca2+. It appears
that of the four Cu2+ ions that bind to the C2B, two of them bind to the
Ca2+ binding domain (data not shown). Two of the Cu2+ ions appear
to bind to another distinct site(s) plausibly contributed by residues in
β-strand II and β-strand IV. Titration of the C2B domain with pS
vesicles shows selective disappearance of crosspeaks in the 1H–15N
HSQC spectrum. The crosspeaks that disappear in the presence of pS
vesicles include, Lys326, Lys327, Thr328, Asn333, and Thr334 (Figs. 2B
and 3B). Some of these residues which bind to pS vesicles also belong
to the Ca2+ binding domain. These observations are in good
agreement with ﬁndings of Rufener et al. [44] who characterized
the lipid binding sites on the C2B domain of Syt1 (in the presence of
Ca2+) using site-directed spin labeling studies. Electron paramagnetic
spin resonance spectroscopy data showed that Val304 and Gly305 in
Loop1, Ile367 and Lys369 in Loop III contribute to lipid binding.
Interestingly, our HSQC data on the C2B domain–pS vesicle interaction
obtained in the absence of Ca2+ did not suggest the involvement ofresence of Cu2+ (in green). Portions of 1H–15N HSQC spectra of the C2B domain (in red)
(in black) (Panel B), pS and Cu2+ (in black) (Panel C). The signiﬁcant decrease in the
he vicinity of the Cu2+ binding site(s).
Fig. 3. Surface diagram representing the structure of C2B domain (green). Residues that show signiﬁcant decrease in intensity in presence of Cu2+ (Panel A), pS (Panel B), pS and
Cu2+ (Panel C) are depicted in red. Titration of the protein (in its free and pS bound forms) with Cu2+ resulted in a signiﬁcant decrease in intensity of crosspeaks of several
residues which are buried in the native conformation of the C2B domain. These buried residues could not be depicted in the surface diagrams shown in this ﬁgure. For example,
crosspeaks of Cys277, Phe278, Leu280 completely disappear when apoC2B domain or C2B domain bound to pS vesicles are titrated with Cu2+.
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Lys369) in binding to pS vesicles. However, HSQC data obtained on
the titration of the pS-bound C2B domain with Ca2+ (data not shown)
showed excellent agreement with the C2B–lipid binding interface
characterized by Rufener et al. [44].
Titration of C2B domain bound to pS vesicles with Cu2+ shows
signiﬁcant loss (N90%) in intensity of 1H–15N crosspeaks (in the HSQC
spectrum) corresponding to Cys277, F278, Ser279, Leu294, Asp309,
Gly320, Lys331, Lys 324 and Gly 384 (Figs. 2C and 3C). These residues
are mostly located in β-strands I and III. The 1H–15N crosspeaks that
disappeared in the presence of pS vesicles remain so in the HSQC
spectrum of the C2B domain obtained in the presence of both Cu2+
and the pS vesicles. Additional crosspeaks of residues which show
signiﬁcant loss in intensity, in the presence of both Cu2+ and pS
vesicles, plausibly further stabilize the C2B-lipid interaction. TheseFig. 4. Cartoon representing the predicted sequence of mresults suggest that Cu2+ increases the lipid binding afﬁnity by
stabilizing interactions in the C2B domain. In summary, the NMR data
clearly suggest that there are two Cu2+ binding sites in the C2B
domain. One of these Cu2+ binding site, contributed by residues in
Loops I, II and III, represents the Ca2+ binding site. In absence of metal
ions, the protein appears to bind to pS vesicles predominantly through
residues in Loop II.
3.2. Possible sequence of molecular events in the non-classical secretion
of hFGF-1
Based on the results of this study and our previous ﬁndings, we
suggest a hypothetical model predicting the sequence of molecular
events that plausibly occur during the Cu2+-mediated non-classical
secretion of hFGF-1 (Fig. 4). The ﬁrst step appears to be an interactionolecular events in the non-classical export of hFGF-1.
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interaction does not require Cu2+ because previously reported ITC
data showed that these proteins interact even in the absence of the
metal ion (Cu2+) [45]. As a next step, the hFGF-1/S100A13 binary
complex plausibly interacts with Syt1 to form the hFGF-1/S100A13/
Syt1 ternary complex. Previous studies from our group and others
suggest that C2A domain is involved in direct interactions with both
hFGF-1 and S100A13 [9,39,45–47]. To-date there is no direct evidence
of direct protein interactions with the C2B domain. Cu2+ binds to
S100A13 [45] and the C2A [47] and C2B domains of Syt1. Cu2+ appears
to be important for, (1) Speciﬁc oxidation of the thiol group of Cys30
to facilitate the formation of a homodimer of hFGF-1; (2) Conferring
stability to the multiprotein complex; and (3) Increasing the lipid
binding afﬁnity of the C2B domain. Although both hFGF-1 and
S100A13 have been shown to bind to lipids, the C2 domains appear to
be critical for anchoring the hFGF-1/S100A13 complex [48]. It is
believed that hFGF-1 is ﬁnally exported across the membrane bilayer
through the ‘ﬂip ﬂop’ action of annexins [9]. In the absence of solid
experimental evidence, the predicted sequence of molecular events
occurring in the non-classical secretion of hFGF-1 should be
considered hypothetical. More detailed studies are currently under-
way to validate some aspects of the proposed mechanism.
Acknowledgements
Wethank theNational Institutes ofHealth (NIHNCRRCOBREGrant 1
P20 RR15569 and 1-K01-CA113753-01A2), the Department of Energy
(Grant DE-FG02-01ER15161) and the Arkansas Biosciences Institute for
ﬁnancial support. SBwas supported by the NSF sponsored REU program
(NSF-REU; Grant Number: CHE-0243978), and LG is a visiting student
from the State Key Laboratory of Bioelectronics, School of Biological
Science and Medical Engineering University, Nanjing, China. He is
supported by China Scholarship Council, Grant Number: 2007U12037.
IP was supported in part by NIH grants ARRA HL35627, HL 35627 and
RR15555 (Project 4), and a grant of Maine Cancer Foundation.
References
[1] M. Landriscina, C. Bagala, A. Mandinova, R. Soldi, I. Micucci, S. Bellum, I. Prudovsky,
T. Maciag, Copper induces the assembly of a multiprotein aggregate implicated in
the release of ﬁbroblast growth factor 1 in response to stress, J. Biol. Chem. 276
(2001) 25549–25557.
[2] C. Di Serio, L. Doria, S. Pellerito, I. Prudovsky, I. Micucci, D. Massi, M. Landriscina, N.
Marchionni, G. Masotti, F. Tarantini, The release of ﬁbroblast growth factor-1 from
melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-
kinase/Akt intracellular signaling pathway, Cancer Lett. 267 (2008) 67–74.
[3] Y.H. Chi, T.K. Kumar, K.M. Kathir, D.H. Lin, G. Zhu, I.M. Chiu, C. Yu, Investigation of
the structural stability of the human acidic ﬁbroblast growth factor by hydrogen-
deuterium exchange, Biochemistry 41 (2002) 15350–15359.
[4] G. Szebenyi, J.F. Fallon, Fibroblast growth factors as multifunctional signaling
factors, Int. Rev. Cytol. 185 (1999) 45–106.
[5] J. Schlessinger, Common and distinct elements in cellular signaling via EGF and
FGF receptors, Science New York, N.Y. 306 (2004) 1506–1507.
[6] M. Korc, R.E. Friesel, The role of ﬁbroblast growth factors in tumor growth, Curr.
Cancer Drug Targets 9 (2009) 639–651.
[7] J. Lee, M. Blaber, The interaction between thermodynamic stability and buried free
cysteines in regulating the functional half-life of ﬁbroblast growth factor-1, J. Mol.
Biol. 393 (2009) 113–127.
[8] R. Friesel, T. Maciag, Fibroblast growth factor prototype release and ﬁbroblast
growth factor receptor signaling, Thromb. Haemost. 82 (1999) 748–754.
[9] I. Prudovsky, F. Tarantini, M. Landriscina, D. Neivandt, R. Soldi, A. Kirov, D. Small,
K.M. Kathir, D. Rajalingam, T.K. Kumar, Secretion without Golgi, J. Cell. Biochem.
103 (2008) 1327–1343.
[10] C. Mouta Carreira, M. Landriscina, S. Bellum, I. Prudovsky, T. Maciag, The
comparative release of FGF1 by hypoxia and temperature stress, Growth factors
(Chur, Switzerland) 18 (2001) 277–285.
[11] A. Jackson, S. Friedman, X. Zhan, K.A. Engleka, R. Forough, T. Maciag, Heat shock
induces the release of ﬁbroblast growth factor 1 from NIH 3T3 cells, Proc. Natl.
Acad. Sci. U. S. A. 89 (1992) 10691–10695.
[12] J.T. Shin, S.R. Opalenik, J.N. Wehby, V.K. Mahesh, A. Jackson, F. Tarantini, T. Maciag,
J.A. Thompson, Serum-starvation induces the extracellular appearance of FGF-1,
Biochim. Biophys. Acta 1312 (1996) 27–38.
[13] N.M. Ananyeva, A.V. Tjurmin, J.A. Berliner, G.M. Chisolm, G. Liau, J.A. Winkles, C.C.
Haudenschild, Oxidized LDL mediates the release of ﬁbroblast growth factor-1,
Arterioscler. Thromb. Vasc. Biol. 17 (1997) 445–453.[14] I. Prudovsky, C. Bagala, F. Tarantini, A. Mandinova, R. Soldi, S. Bellum, T. Maciag,
The intracellular translocation of the components of the ﬁbroblast growth factor 1
release complex precedes their assembly prior to export, J. Cell Biol. 158 (2002)
201–208.
[15] O.H. Shin, J. Xu, J. Rizo, T.C. Sudhof, Differential but convergent functions of Ca2+
binding to synaptotagmin-1 C2 domains mediate neurotransmitter release, Proc.
Natl. Acad. Sci. U. S. A. 106 (2009) 16469–16474.
[16] W. Kuo, D.Z. Herrick, J.F. Ellena, D.S. Caﬁso, The calcium-dependent and calcium-
independent membrane binding of synaptotagmin 1: twomodes of C2B binding, J.
Mol. Biol. 387 (2009) 284–294.
[17] I. Graziani, A. Doyle, S. Sterling, A. Kirov, F. Tarantini, M. Landriscina, T.K. Kumar, D.
Neivandt, I. Prudovsky, Protein folding does not prevent the nonclassical export of
FGF1 and S100A13, Biochem. Biophys. Res. Commun. 381 (2009) 350–354.
[18] R. Soldi, A. Mandinova, K. Venkataraman, T. Hla, M. Vadas, S. Pitson, M. Duarte, I.
Graziani, V. Kolev, D. Kacer, A. Kirov, T. Maciag, I. Prudovsky, Sphingosine kinase 1
is a critical component of the copper-dependent FGF1 export pathway, Exp. Cell
Res. 313 (2007) 3308–3318.
[19] T.M. LaVallee, I.A. Prudovsky, G.A. McMahon, X. Hu, T. Maciag, Activation of the
MAP kinase pathway by FGF-1 correlates with cell proliferation induction while
activation of the Src pathway correlates with migration, J. Cell Biol. 141 (1998)
1647–1658.
[20] F. Tarantini, T. LaVallee, A. Jackson, S. Gamble, C. Mouta Carreira, S. Garﬁnkel, W.H.
Burgess, T. Maciag, The extravesicular domain of synaptotagmin-1 is released
with the latent ﬁbroblast growth factor-1 homodimer in response to heat shock, J.
Biol. Chem. 273 (1998) 22209–22216.
[21] M. Landriscina, R. Soldi, C. Bagala, I. Micucci, S. Bellum, F. Tarantini, I. Prudovsky, T.
Maciag, S100A13 participates in the release of ﬁbroblast growth factor 1 in
response to heat shock in vitro, J. Biol. Chem. 276 (2001) 22544–22552.
[22] R. Fernandez-Chacon, O.H. Shin, A. Konigstorfer, M.F.Matos, A.C.Meyer, J. Garcia, S.
H. Gerber, J. Rizo, T.C. Sudhof, C. Rosenmund, Structure/function analysis of Ca2+
binding to the C2A domain of synaptotagmin 1, J. Neurosci. 22 (2002) 8438–8446.
[23] S.H. Gerber, J. Rizo, T.C. Sudhof, Role of electrostatic and hydrophobic interactions
in Ca(2+)-dependent phospholipid binding by the C(2)A-domain from synapto-
tagmin I, Diabetes 51 (Suppl. 1) (2002) S12–18.
[24] E. Hui, J. Bai, P. Wang, M. Sugimori, R.R. Llinas, E.R. Chapman, Three distinct kinetic
groupings of the synaptotagmin family: candidate sensors for rapid and delayed
exocytosis, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5210–5214.
[25] J. Bai, E.R. Chapman, The C2 domains of synaptotagmin—partners in exocytosis,
Trends Biochem. Sci. 29 (2004) 143–151.
[26] K.L. Fuson, L. Ma, R.B. Sutton, A.F. Oberhauser, The c2 domains of human
synaptotagmin 1 have distinct mechanical properties, Biophys. J. 96 (2009)
1083–1090.
[27] D. Rajalingam, T.K. Kumar, C. Yu, The C2A domain of synaptotagmin exhibits a
high binding afﬁnity for copper: implications in the formation of the multiprotein
FGF release complex, Biochemistry 44 (2005) 14431–14442.
[28] C. Bagala, V. Kolev, A. Mandinova, R. Soldi, C. Mouta, I. Graziani, I. Prudovsky, T.
Maciag, The alternative translation of synaptotagmin 1mediates the non-classical
release of FGF1, Biochem. Biophys. Res. Commun. 310 (2003) 1041–1047.
[29] S.S. Sukumaran, S. Banerjee, S. Bhasker, A. Thekkuveettil, The cytoplasmic C2A
domain of synaptotagmin shows sequence speciﬁc interaction with its own
mRNA, Biochem. Biophys. Res. Commun. 373 (2008) 509–514.
[30] K. Duning, F. Buck, A. Barnekow, J. Kremerskothen, SYNCRIP, a component of
dendritically localized mRNPs, binds to the translation regulator BC200 RNA,
J. Neurochem. 105 (2008) 351–359.
[31] T.M. LaVallee, F. Tarantini, S. Gamble, C. Mouta Carreira, A. Jackson, T. Maciag,
Synaptotagmin-1 is required for ﬁbroblast growth factor-1 release, J. Biol. Chem.
273 (1998) 22217–22223.
[32] I. Graziani, C. Bagala, M. Duarte, R. Soldi, V. Kolev, F. Tarantini, T.K. Kumar, A. Doyle,
D. Neivandt, C. Yu, T. Maciag, I. Prudovsky, Release of FGF1 and p40 synaptotagmin
1 correlates with their membrane destabilizing ability, Biochem. Biophys. Res.
Commun. 349 (2006) 192–199.
[33] I. Fernandez, D. Arac, J. Ubach, S.H. Gerber, O. Shin, Y. Gao, R.G. Anderson, T.C. Sudhof,
J. Rizo, Three-dimensional structure of the synaptotagmin 1 C2B-domain:
synaptotagmin 1 as a phospholipid bindingmachine, Neuron 32 (2001) 1057–1069.
[34] J. Ubach, Y. Lao, I. Fernandez, D. Arac, T.C. Sudhof, J. Rizo, The C2B domain of
synaptotagmin I is a Ca2+-binding module, Biochemistry 40 (2001) 5854–5860.
[35] A. Radhakrishnan, A. Stein, R. Jahn, D. Fasshauer, The Ca2+ afﬁnity of
synaptotagmin 1 is markedly increased by a speciﬁc interaction of its C2B
domain with phosphatidylinositol 4,5-bisphosphate, J. Biol. Chem. 284 (2009)
25749–25760.
[36] P. Montaville, C. Schlicker, A. Leonov, M. Zweckstetter, G.M. Sheldrick, S. Becker,
The C2A-C2B linker deﬁnes the high afﬁnity Ca(2+) binding mode of rabphilin-
3A, J. Biol. Chem. 282 (2007) 5015–5025.
[37] J.Y. Jang, T. Krishnaswamy, S. Kumar, G. Jayaraman, P.W. Yang, C. Yu, Comparison
of the hemolytic activity and solution structures of two snake venom cardiotoxin
analogues which only differ in their N-terminal amino acid, Biochemistry 36
(1997) 14635–14641.
[38] A.I. Arunkumar, S. Srisailam, T.K. Kumar, K.M. Kathir, Y.H. Chi, H.M. Wang, G.G.
Chang, I. Chiu, C. Yu, Structure and stability of an acidic ﬁbroblast growth factor
from Notophthalmus viridescens, J. Biol. Chem. 277 (2002) 46424–46432.
[39] T.D. Goddard, D.G. Kueller, SPARKY 3, University of California, San Francisco, 2006.
[40] P.J. Hajduk, R.P. Meadows, S.W. Fesik, NMR-based screening in drug discovery,
Q. Rev. Biophys. 32 (1999) 211–240.
[41] L. Yu, T.K. Oost, J.M. Schkeryantz, J. Yang, D. Janowick, S.W. Fesik, Discovery of
aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA,
J. Am. Chem. Soc. 125 (2003) 4444–4450.
302 K.M. Kathir et al. / Biochimica et Biophysica Acta 1798 (2010) 297–302[42] E.R. Zuiderweg, Mapping protein-protein interactions in solution by NMR
spectroscopy, Biochemistry 41 (2002) 1–7.
[43] I. Bertini, C. Luchinat, M. Piccioli, Paramagnetic probes in metalloproteins,
Methods Enzymol. 339 (2001) 314–340.
[44] E. Rufener, A.A. Frazier, C.M. Wieser, A. Hinderliter, D.S. Caﬁso, Membrane-bound
orientation and position of the synaptotagmin C2B domain determined by site-
directed spin labeling, Biochemistry 44 (2005) 18–28.
[45] V. Sivaraja, T.K.S. Kumar, D. Rajalingam, I. Graziani, I. Prudovsky, C. Yu, Copper
binding afﬁnity of S100A13, a key component of the FGF-1 nonclassical copper-
dependent release complex, Biophys. J. 91 (2006) 1832–1843.[46] I. Prudovsky, A. Mandinova, R. Soldi, C. Bagala, I. Graziani, M. Landriscina, F.
Tarantini, M. Duarte, S. Bellum, H. Doherty, T. Maciag, The non-classical export
routes: FGF1 and IL-1alpha point the way, J. Cell. Sci. 116 (2003) 4871–4881.
[47] A. Mandinova, R. Soldi, I. Graziani, C. Bagala, S. Bellum, M. Landriscina, F. Tarantini,
I. Prudovsky, T. Maciag, S100A13 mediates the copper-dependent stress-induced
release of IL-1alpha from both human U937 and murine NIH 3T3 cells, J. Cell. Sci.
116 (2003) 2687–2696.
[48] K.M. Kathir, K. Ibrahim, D. Rajalingam, I. Prudovsky, C. Yu, T.K.S. Kumar, S100A13-
lipid interactions-role in the non-classical release of the acidic ﬁbroblast growth
factor, Biochim. Biophys. Acta 1768 (2007) 3080–3089.
